Cao Dai Phung

1.3k citations
33 papers · 1.0k indexed · h-index 20
Topics
Immunotherapy and Immune Responses (14 papers)Nanoplatforms for cancer theranostics (13 papers)RNA Interference and Gene Delivery (11 papers)
Journals
SHILAP Revista de lepidopterologíaBiomaterialsAdvanced Functional Materials

In The Last Decade

Cao Dai Phung

33 papers receiving 1.0k citations

Peers

Cao Dai Phung
Comparison fields: 5 of 90
  • Biomedical Engineering 509
  • Molecular Biology 407
  • Immunology 350
  • Biomaterials 296
  • Oncology 191
Replace Brandon Piel with:
Brandon Piel United States
Suxin Li China
Kuo‐Ching Mei United States
Aihua Wu China
Zhanwei Zhou China
Binfan Chen China
Alexandros Marios Sofias Germany
Md. Nazir Hossen United States
Cao Dai Phung relative to Brandon Piel United States Brandon Piel's profile →
Citations per field
00.5×1.5×
Brandon Piel · 1×
Citations per year

Countries citing papers authored by Cao Dai Phung

Since Specialization
Citations

This map shows the geographic impact of Cao Dai Phung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cao Dai Phung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cao Dai Phung more than expected).

Fields of papers citing papers by Cao Dai Phung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cao Dai Phung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cao Dai Phung. The network helps show where Cao Dai Phung may publish in the future.

Co-authorship network of co-authors of Cao Dai Phung

This figure shows the co-authorship network connecting the top 25 collaborators of Cao Dai Phung. A scholar is included among the top collaborators of Cao Dai Phung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cao Dai Phung. Cao Dai Phung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 14
2 12
3 10
4 14
5 102
6 21
7 54
8 26
9 31
10 28
11 41
12 28
13 33
14 30
15 33
16 62
17 65
18 28
19 14
20 42

About Cao Dai Phung

Cao Dai Phung is a scholar working on Immunology, Biomaterials and Biomedical Engineering, having authored 33 papers that have together received 1.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (14 papers), Nanoplatforms for cancer theranostics (13 papers) and RNA Interference and Gene Delivery (11 papers). The work is most often cited by research in Biomaterials (296 citations), Immunology (350 citations) and Biomedical Engineering (509 citations). Cao Dai Phung has collaborated with scholars based in South Korea, Vietnam and United States. Frequent co-authors include Jong Oh Kim, Jee‐Heon Jeong, Hanh Thuy Nguyen, Chul Soon Yong, Tuan Hiep Tran, Han‐Gon Choi, Sae‐Kwang Ku, Le Minh Pham, Tung Thanh Pham and Chul Soon Yong. Their work appears in journals such as SHILAP Revista de lepidopterología, Biomaterials and Advanced Functional Materials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026